| Drug | Class | Adult | Paediatric | Notes |
|---|---|---|---|---|
| Oral elemental iron (ferrous sulphate, fumarate, gluconate, or polymaltose)[1] | Iron salt | Established IDA: 100–200 mg elemental iron PO daily (or alternate-day for tolerance); empty stomach with vitamin C; reassess Hb in 2–4 weeks | Adolescent pregnancies: 60–120 mg elemental iron daily | First-line for mild–moderate IDA; nausea, constipation common — alternate-day dosing improves absorption per hepcidin physiology; iron polymaltose has fewer GI side effects |
| Intravenous iron — ferric carboxymaltose, iron sucrose, ferric derisomaltose[1] | Parenteral iron | Ferric carboxymaltose 1000 mg IV single dose (max 1000 mg/week, 2000 mg total); iron sucrose 200 mg IV per session × multiple sessions to total dose; ferric derisomaltose up to 20 mg/kg single infusion | — | Indications: oral iron intolerance or non-response, severe anaemia (Hb <90 g/L) at >34 weeks, malabsorption, or rapid repletion before delivery. Avoid first trimester unless severe; monitor for hypersensitivity, hypophosphataemia (FCM) |
Screening, oral and intravenous iron repletion, and transfusion thresholds for iron deficiency anaemia in pregnancy and the puerperium.